Not reported
Active09981769Private limited companyWatlington
FAST BIOPHARMA LTD
Significant control: Alderley Park Ventures Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Fast Biopharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Fast Biopharma Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
FAST BIOPHARMA LTD is an active private limited company (company number 09981769) incorporated on 2 February 2016, registered in Watlington. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 January 2026 and cash of £6,642, with 4 employees on average.
There are 152 companies in research and experimental development on biotechnology in Oxford with filed accounts; the median reports net assets of £10k and is 7 years old.
02
Ownership and control
- Alderley Park Ventures Limited
- owns 25–50% of shares
- Dr Peter David Davis
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 2 February 201610 yrs ago
- Next accounts due
- 31 October 2027in 371 days
- Confirmation statement due
- 16 February 2027in 114 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£6,642
−31%vs Jan 2025Not reported
4
No changevs Jan 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | — | £6,642 | — | £2,450 | — | — | 4 |
| 31 January 2025 | — | £9,689 | £150 | — | — | — | 4 |
| 31 January 2024 | — | £13k | £71 | — | — | — | 4 |
Current ratio2.77Current assets ÷ creditors within one year
Cash per employee£1,660Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.77
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 2 February 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 371 days
- Confirmation statement duein 114 days
- Accounts period end
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in Oxford
- ARCTORIS LTDAbingdon · inc. Feb 2016
- ARGONAUT THERAPEUTICS LIMITEDOxford · inc. Feb 2016
- OSLER DIAGNOSTICS LIMITEDOxford · inc. Feb 2016
- GYLDEN PHARMA LIMITEDAbingdon · inc. Jan 2016
- OMASS THERAPEUTICS LIMITEDOxford · inc. Feb 2016
- TAILORED CLINICAL RESEARCH SOLUTIONS LIMITEDOxford · inc. Dec 2015
All companies incorporated on 2 February 2016 · in Feb 2016.
09
Reminders for FAST BIOPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.